文献速递主动脉疾病

血管质量倡议登记、Medicare理赔与病历审查对血管内动脉瘤修复术后再干预率的比较

A comparison of reintervention rates after endovascular aneurysm repair between the Vascular Quality Initiative registry, Medicare claims, and chart review.
PubMed 文献 · J Vasc Surg · 2018-06-15

本研究比较了729例2003至2013年在本中心接受EVAR的患者中,VQI单独、VQI链接Medicare理赔及病历审查联合电话访谈(金标准)三种数据来源的再干预率。最终分析队列547例,VQI-Medicare与病历审查1年一致性极好(κ=0.93),3年再干预率VQI-Medicare为18%、病历审查为16%,敏感性92%、特异性96%、κ=0.80,Log-rank检验P=0.59。结论认为VQI-Medicare可准确评估EVAR术后再干预率。

要点

  • 病历审查显示EVAR术后1年再干预率为6%,3年再干预率为16%。
  • VQI-Medicare数据在1年识别所有30例再干预事件,与病历审查一致性极好(κ=0.93)。
  • 3年时VQI-Medicare检测到81例(18%)再干预,病历审查检测到70例(16%),敏感性92%、特异性96%、κ=0.80。

核心结论

  • 病历审查显示EVAR术后1年再干预率为6%、3年再干预率为16%,其中92%的事件被VQI-Medicare数据准确捕获。
  • 将VQI数据与Medicare理赔链接可准确评估EVAR术后再干预率,无需费力的医生病历审查。

研究设计与样本

  • 回顾性研究,审查2003至2013年在本中心接受EVAR的729例患者病历。
  • 排除未向VQI报告随访者(n=68,9%)或无Medicare理赔信息者(n=114,16%),最终分析队列547例,均有三种数据来源的随访信息。
  • 比较VQI单独、VQI链接Medicare及病历审查联合电话访谈(金标准)的再干预率,主要终点为三种数据来源间的一致性及EVAR术后1年、2年、3年再干预的Kaplan-Meier估计率。

主要发现

  • VQI单独数据在EVAR术后第一年识别12例再干预事件,病历审查确认全部12例并额外发现18例VQI未捕获的事件。
  • VQI-Medicare数据成功识别第一年全部30例再干预事件,并记录4例(4/547,0.7%)经患者访谈确认未发生的再干预。
  • 1年时病历审查与VQI-Medicare数据一致性极好(κ=0.93)。
  • 3年时VQI-Medicare检测到81例(18%)再干预,病历审查检测到70例(16%),敏感性92%、特异性96%、κ=0.80。
  • Kaplan-Meier生存分析显示3年后VQI-Medicare与病历审查的再干预率相似(Log-rank检验,P=0.59)。

临床怎么用

  • 作者认为将VQI数据与Medicare理赔链接可准确评估EVAR术后再干预率,无需费力的医生病历审查。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The accurate measurement of reintervention after endovascular aneurysm repair (EVAR) is critical during postoperative surveillance. The purpose of this study was to compare reintervention rates after EVAR from three different data sources: the Vascular Quality Initiative (VQI) alone, VQI linked to Medicare claims (VQI-Medicare), and a "gold standard" of clinical chart review supplemented with telephone interviews. METHODS: We reviewed the medical records of 729 patients who underwent EVAR at our institution between 2003 and 2013. We excluded patients without follow-up reported to the VQI (n = 68 [9%]) or without Medicare claims information (n = 114 [16%]). All patients in the final analytic cohort (n = 547) had follow-up information available from all three data sources (VQI alone, VQI linked to Medicare, and chart review). We then compared reintervention rates between the three data sources. Our primary end points were the agreement between the three data sources and the Kaplan-Meier estimated rate of reintervention at 1 year, 2 years, and 3 years after EVAR. For gold standard assessment, we supplemented chart review with telephone interview as necessary to assess reintervention. RESULTS: VQI data alone identified 12 reintervention events in the first year after EVAR. Chart review confirmed all 12 events and identified 18 additional events not captured by the VQI. VQI-Medicare data successfully identified all 30 of these events within the first year. VQI-Medicare also documented four reinterventions in this time period that did not occur on the basis of patient interview (4/547 [0.7%]). The agreement between chart review and VQI-Medicare data at 1 year was excellent (κ = 0.93). At 3 years, there were 81 (18%) reinterventions detected by VQI-Medicare and 70 (16%) detected by chart review for a sensitivity of 92%, specificity of 96%, and κ of 0.80. Kaplan-Meier survival analysis demonstrated similar reintervention rates after 3 years between VQI-Medicare and chart review (log-rank, P = .59). CONCLUSIONS: Chart review after EVAR demonstrated a 6% 1-year and 16% 3-year reintervention rate, and almost all (92%) of these events were accurately captured using VQI-Medicare data. Linking VQI data with Medicare claims allows an accurate assessment of reintervention rates after EVAR without labor-intensive physician chart review.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Columbo JA, Kang R, Hoel AW, et al. A comparison of reintervention rates after endovascular aneurysm repair between the Vascular Quality Initiative registry, Medicare claims, and chart review. J Vasc Surg. 2018. PMID: 29914838. doi:10.1016/j.jvs.2018.03.423

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。